Endocrinology, Vol 130, 789-796, Copyright © 1992 by Endocrine Society

ARTICLES

Purification and characterization of high molecular weight forms of inhibin from bovine follicular fluid

K Sugino, T Nakamura, K Takio, K Miyamoto, Y Hasegawa, M Igarashi, K Titani and H Sugino
Frontier Research Program, Institute of Physical and Chemical Research (RIKEN), Saitama, Japan.

High molecular mass forms [95 kilodaltons (kDa)] of bovine inhibin-A as well as the known forms of intermediate (55 kDa) and low (32 kDa) mass were purified from bovine follicular fluid by ion exchange chromatography on DEAE-Sepharose, immunoaffinity chromatography using a monoclonal antibody directed against bovine 32-kDa inhibin-A, gel permeation HPLC on TSK-gel, and reverse phase HPLC. The 95-kDa inhibin- A had similar suppressive activity on FSH secretion from cultured rat anterior pituitary cells as the 55- and 32-kDa inhibins. There is, however, a possibility that the inhibin activity detected with larger forms may be due to that of the 32-kDa form that results from proteolytic processing during incubation with rat pituitary cells. Both sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting analysis using monoclonal antibodies specific for 32- kDa inhibin alpha- or beta A-subunits revealed that the 95-kDa inhibin preparation contained two forms of inhibin (105 and 95 kDa), which were composed of either a 50- or a 40-kDa alpha-subunit linked by a disulfide bond(s) to a 55-kDa beta A-subunit. Amino-terminal sequence analysis showed that the 50-kDa alpha-subunit and the 55-kDa beta A- subunit were generated by removal of a signal peptide from each corresponding primary translation product [the first NH2-terminal 17 residues of the inhibin alpha-subunit (residues 1-360) and the first 20 residues of the inhibin beta A-subunit (residues 1-425)] and suggested that the 40-kDa alpha-subunit was formed by proteolytic processing of the 50-kDa alpha-subunit. On the basis of our findings, we propose that in bovine follicular fluid, the larger 105-kDa form of inhibin is processed successively to form the lowest molecular mass form, 32 kDa inhibin, through the smaller 95- and 55-kDa forms.

This article has been cited by other articles:

				H. Kaneko, J. Noguchi, K. Kikuchi, and Y. Hasegawa Molecular Weight Forms of Inhibin A and Inhibin B in the Bovine Testis Change with Age Biol Reprod, May 1, 2003; 68(5): 1918 - 1925. [Abstract] [Full Text] [PDF]

				H. Kaneko, J. Todoroki, J. Noguchi, K. Kikuchi, K. Mizoshita, C. Kubota, and H. Yamakuchi Perturbation of Estradiol-Feedback Control of Luteinizing Hormone Secretion by Immunoneutralization Induces Development of Follicular Cysts in Cattle Biol Reprod, December 1, 2002; 67(6): 1840 - 1845. [Abstract] [Full Text] [PDF]

				H. Kaneko, J. Noguchi, K. Kikuchi, J. Todoroki, and Y. Hasegawa Alterations in Peripheral Concentrations of Inhibin A in Cattle Studied Using a Time-Resolved Immunofluorometric Assay: Relationship with Estradiol and Follicle-Stimulating Hormone in Various Reproductive Conditions Biol Reprod, July 1, 2002; 67(1): 38 - 45. [Abstract] [Full Text] [PDF]

				G. P. Risbridger, J. F. Schmitt, and D. M. Robertson Activins and Inhibins in Endocrine and Other Tumors Endocr. Rev., December 1, 2001; 22(6): 836 - 858. [Abstract] [Full Text] [PDF]

				C. Cariou-Guennoc, J.C. Poirier, B. Calas, A. Locatelli, J.L. Dacheux, and M.R. Blanc Evidence That Luteinizing Hormone-Releasing Hormone Statin from Ovine Rete Testis Fluid Is Immunologically Related to {alpha}C Inhibin Biol Reprod, June 1, 2000; 62(6): 1551 - 1563. [Abstract] [Full Text]

				M. Bläuer, S. Husgafvel, H. Syvälä, P. Tuohimaa, and T. Ylikomi Identification of a Nuclear Localization Signal in Activin/Inhibin ßA Subunit; Intranuclear ßA in Rat Spermatogenic Cells Biol Reprod, March 1, 1999; 60(3): 588 - 593. [Abstract] [Full Text]

				D. M. Robertson, N. Cahir, J. K. Findlay, H. G. Burger, and N. Groome The Biological and Immunological Characterization of Inhibin A and B Forms in Human Follicular Fluid and Plasma J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 889 - 896. [Abstract] [Full Text] [PDF]